← Back to Clinical Trials
Recruiting NCT06233513

NCT06233513 Vowel Space Expansion Sensorimotor Adaptation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06233513
Status Recruiting
Phase
Sponsor University of Wisconsin, Madison
Condition Speech
Study Type INTERVENTIONAL
Enrollment 117 participants
Start Date 2024-02-15
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Exp 3 Speaking Task

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 117 participants in total. It began in 2024-02-15 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds. 117 participants will be enrolled into this part of the study and can expect to be on study between 1 day (Experiment 1) and 4 weeks (Experiment 2).

Eligibility Criteria

Inclusion Criteria: * English-speaking adults * normal hearing and speech * no history of stroke or neurological conditions Exclusion Criteria: * Native language other than English * Any neurological disorders other than the disorder of interest * Any history of hearing disorders * Uncorrected vision problems that prevent participants from seeing visually-presented stimuli * Significant cognitive impairments that prevent participants from carrying out the task or from giving informed consent * Vulnerable populations (minors and prisoners)

Contact & Investigator

Central Contact

Carrie Niziolek, PhD

✉ cniziolek@wisc.edu

📞 608-890-0192

Principal Investigator

Carrie Niziolek, PhD

PRINCIPAL INVESTIGATOR

University of Wisconsin, Madison

Frequently Asked Questions

Who can join the NCT06233513 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Speech. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06233513 currently recruiting?

Yes, NCT06233513 is actively recruiting participants. Contact the research team at cniziolek@wisc.edu for enrollment information.

Where is the NCT06233513 trial being conducted?

This trial is being conducted at Madison, United States.

Who is sponsoring the NCT06233513 clinical trial?

NCT06233513 is sponsored by University of Wisconsin, Madison. The principal investigator is Carrie Niziolek, PhD at University of Wisconsin, Madison. The trial plans to enroll 117 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology